VDRM FULL DD PACKAGE
ALL THE DD ON VDRM YOU NEED RIGHT HERE (repost)
2dollarbill Saturday, 08/19/17 10:19:12 AM
Re: None
Post #
26410
of 26411 Go
ALL THE DD ON VDRM YOU NEED RIGHT HERE
FDA approved products that ViaDerma (VDRM) offers:
-skin cancer therapies (Cantrile)
-stem cell therapy product (TetraStem Plus)
-topical antibiotics (TetraStem the world’s strongest broad-spectrum topical antibiotic available)
-TETRA-STEM – a tetracycline hydrochloride ointment. An award-winning antibiotic/wound healing product that kills all knows bacteria, including "flesh-eating" bacteria. Tertra-stem also can be used to treat wounds, ulcers
-topical anti-viral product (Viralcur) for genital herpes anti-fungal products for onychomycocis (OnyPro)
-hair loss prevention product (HairGain)
-ACNECLIR/ACNEEN – a salicylic acid based lotion that treats acne
-ECODERM – a colloidal oatmeal lotion for Eczema
-ACNECYCLINE – a tetracycline hydrochloride ointment that treats acne
-DERMONEEN – a salicylic acid lotion used to treat Psoriasis
-IVYMED – a zinc acetate based liquid that treats Poison Ivy rashes
- STAPHWASH PLUS – a zinc acetate based liquid. This is a non-antibiotic skin cleanser that kills MRSA
-TETRA-ABC – a tetracycline hydrochloride based ointment. This is an oil based topical antibiotic that kills all known bacterial infections. A water based version of this product is also available.
-STINGMED – a zinc acetate based liquid that treats most insect and spider bites
-ADVANCED JELLYFISH STING KIT – a zinc acetate powder, for suspension, that treats Jellyfish stings
-VENOMX – a zinc acetate based liquid used topically to treat snake bites.
-Product for treatment of Migraines presently; with a future of possibly ( inflammation of fibromyalgia, Cohn’s disease, nicotine addiction, schizophrenia, and pain management for Multiple Sclerosis and cancer. utilizing (CBD's) Calanoids and (THC) Tetrahydrocannabinol
biotechs trade at 30x earnings or 5x gross sales or 15x net sales or on air if they are a r and d company, with VDRM we have sales coming this year here is the analysis broken down below
ie...from the 500,000 bottles alone will yield 62.5M gross sales
62.5m in gross sales X 5x gross sales = 325m market cap = $1.00 - $1.50 target
OR
62.5m in gross sales @ a 50% margin = 331M in net sales X 15x net sales = 450m market cap = $2.00 + target
OR
62.5m in gross sales with a 331M in net sales which divided by outstanding stock = 0.15 cents earnings X 30x earnings (pe - price to earnings) = $4.50 + target
Lead Product TetraStem
World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results. Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Very low water content and optimum (low) viscosity. Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.
Potential Markets
ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $3.02 billion/year
Psoriasis- $7.3 billion/year
Eczema- $2.5 billion/year
Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transformoral medication into topical products. Ability to enable active ingredients with a rapid transport direct to the site of action.
Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life. Facilitates transfer of chemicals through the stratum corneum with
2dollarbill Saturday, 08/19/17 10:19:12 AM
Re: None
Post #
26410
of 26411 Go
ALL THE DD ON VDRM YOU NEED RIGHT HERE
FDA approved products that ViaDerma (VDRM) offers:
-skin cancer therapies (Cantrile)
-stem cell therapy product (TetraStem Plus)
-topical antibiotics (TetraStem the world’s strongest broad-spectrum topical antibiotic available)
-TETRA-STEM – a tetracycline hydrochloride ointment. An award-winning antibiotic/wound healing product that kills all knows bacteria, including "flesh-eating" bacteria. Tertra-stem also can be used to treat wounds, ulcers
-topical anti-viral product (Viralcur) for genital herpes anti-fungal products for onychomycocis (OnyPro)
-hair loss prevention product (HairGain)
-ACNECLIR/ACNEEN – a salicylic acid based lotion that treats acne
-ECODERM – a colloidal oatmeal lotion for Eczema
-ACNECYCLINE – a tetracycline hydrochloride ointment that treats acne
-DERMONEEN – a salicylic acid lotion used to treat Psoriasis
-IVYMED – a zinc acetate based liquid that treats Poison Ivy rashes
- STAPHWASH PLUS – a zinc acetate based liquid. This is a non-antibiotic skin cleanser that kills MRSA
-TETRA-ABC – a tetracycline hydrochloride based ointment. This is an oil based topical antibiotic that kills all known bacterial infections. A water based version of this product is also available.
-STINGMED – a zinc acetate based liquid that treats most insect and spider bites
-ADVANCED JELLYFISH STING KIT – a zinc acetate powder, for suspension, that treats Jellyfish stings
-VENOMX – a zinc acetate based liquid used topically to treat snake bites.
-Product for treatment of Migraines presently; with a future of possibly ( inflammation of fibromyalgia, Cohn’s disease, nicotine addiction, schizophrenia, and pain management for Multiple Sclerosis and cancer. utilizing (CBD's) Calanoids and (THC) Tetrahydrocannabinol
biotechs trade at 30x earnings or 5x gross sales or 15x net sales or on air if they are a r and d company, with VDRM we have sales coming this year here is the analysis broken down below
ie...from the 500,000 bottles alone will yield 62.5M gross sales
62.5m in gross sales X 5x gross sales = 325m market cap = $1.00 - $1.50 target
OR
62.5m in gross sales @ a 50% margin = 331M in net sales X 15x net sales = 450m market cap = $2.00 + target
OR
62.5m in gross sales with a 331M in net sales which divided by outstanding stock = 0.15 cents earnings X 30x earnings (pe - price to earnings) = $4.50 + target
Lead Product TetraStem
World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results. Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Very low water content and optimum (low) viscosity. Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.
Potential Markets
ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $3.02 billion/year
Psoriasis- $7.3 billion/year
Eczema- $2.5 billion/year
Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transformoral medication into topical products. Ability to enable active ingredients with a rapid transport direct to the site of action.
Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life. Facilitates transfer of chemicals through the stratum corneum with
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.